Zhejiang Huahai Pharmaceutical (600521.SH): The formulation product Gabapentin Capsules has obtained the approval number from the US FDA.

17:27 10/03/2026

Huahai Pharmaceutical (600521.SH) announced that its subsidiary, Pulinstone Pharmaceutical Co., Ltd., has recently received approval from the United States Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA) of Gabapentin Capsules. Gabapentin Capsules are mainly used for the treatment of post-herpetic neuralgia in adults.

Zhejiang Huahai Pharmaceutical (600521.SH) announced that its subsidiary Pu Lin Stone Pharmaceutical Co., Ltd. has recently received approval from the U.S. Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA) of Gabapentin Capsules. Gabapentin Capsules are mainly used for the treatment of postherpetic neuralgia in adults.

STANCHART (02888) awarded approximately 17.88 million shares as a reward.

SMART DIGI TECH (01159) signed a cooperation intention agreement with Hong Kong Satellite Communications for direct mobile satellite connections.

American coal companies are now venturing into rare earth mining! Ramaco (METC.US) has teamed up with Japanese companies to promote the localization of the rare earth industry chain in the United States.

STANCHART (02888) awarded approximately 17.88 million shares as a reward.

SMART DIGI TECH (01159) signed a cooperation intention agreement with Hong Kong Satellite Communications for direct mobile satellite connections.